You are here: Industry Insights > EC

News List

Celltrion secures EC approval for Remsima SC for five more indications pharmaceutical-business-review
July 29, 2020
Celltrion Healthcare has secured approval from the European Commission (EC) for the subcutaneous (SC) formulation of autoimmune disease drug Remsima (infliximab, CT-P13) for the treatment of five more indications.
EC approves new indication for Boehringer’s nintedanib in pulmonary fibrosis pharmaceutical-business-review
July 17, 2020
Boehringer Ingelheim has secured approval for a new indication of nintedanib to treat adults with other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype beyond idiopathic pulmonary fibrosis (IPF).
Novartis receives EC approval for Enerzair Breezhaler americanpharmaceuticalreview
July 16, 2020
Novartis announced the European Commission (EC) has approved Enerzair® Breezhaler® (QVM149; indacaterol acetate, glycopyrronium bromide and mometasone furoate [IND/GLY/MF]) as a maintenance treatment of asthma in adult patients not adequately ...
CureVac recieves €75 million loan for vaccine development and manufacturing expansion europeanpharmaceuticalreview
July 09, 2020
The European Investment Bank (EIB) will provide three €25 million instalments to support CureVac’s vaccine development and expansion to mRNA production facilities.
Novartis banks EC approval for Enerzair Breezhaler pharmatimes
July 08, 2020
The European Commission (EC) has approved Novartis' Enerzair Breezhaler (indacaterol acetate, glycopyrronium bromide and mometasone furoate) for uncontrolled asthma.
FDA, EC Partner on COVID-19 Response americanpharmaceuticalreview
July 07, 2020
The European Union (EU) is one of the U.S. Food and Drug Administration’s most important collaborators in tackling public heath challenges.
Gilead gets EC conditional approval for remdesivir to treat Covid-19 pharmaceutical-technology
July 07, 2020
The European Commission (EC) has provided conditional marketing authorisation for Gilead Sciences to use Veklury (remdesivir) for the treatment of Covid-19.
Further billions pledged to ensure equitable access to COVID-19 treatments europeanpharmaceuticalreview
July 03, 2020
The European Investment Bank (EIB), in partnership with the European Commission (EC), have pledged an additional €4.9 billion for use in the global coronavirus response funds.
Janssen’s Ebola vaccine secures European regulatory approval pharmaceutical-technology
July 03, 2020
Johnson & Johnson unit Janssen Pharmaceutical Companies has received marketing authorisation from the European Commission (EC) for its vaccine regimen designed to prevent Ebola Virus Disease.
Pfizer gets EC approval for Daurismo to treat newly diagnosed acute myeloid leukaemia pharmaceutical-business-review
July 02, 2020
Pfizer has secured approval from the European Commission (EC) for its Daurismo (glasdegib) to treat certain adult patients with newly diagnosed acute myeloid leukaemia (AML).

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page